When Mutation Counters Infection: From Sickle Cell to Ebola

 While pharmaceutical companies focus on drug discovery for Ebola virus disease, a powerful clue is coming from a rare “Jewish genetic disease” that destroys the brain. People with Niemann-Pick C1 disease can’t get Ebola, adding to the list of disease … Continue reading »

The post When Mutation Counters Infection: From Sickle Cell to Ebola appeared first on PLOS Blogs Network.